Clinical Trial Supplies Market Opportunities To Reach $3.3 Billion By 2025

San Francisco, 04 April 2019 –  “Clinical Trial Supplies Market Analysis By Phase (Phase I, Phase II, Phase III), By Product & Services (Manufacturing, Storage & Distribution, Supply Chain Management), By End-Use, By Therapeutic Use, By Region, And Segment Forecasts, [2018 - 2025]”

The global clinical trial supplies market is expected to reach USD 3.3 billion by 2025, according to a new report by Grand View Research, Inc. The market is expected to witness growth at 7.3% CAGR owing to Increasing volume of clinical trial studies coupled with the growing complexity in conduction of these trials are the primary driver of the industry. Furthermore, geographic expansion and development of Information Technology (IT) to facilitate higher integration and smooth performance of activities are other vitally impacting parameters. Over the next eight years, the clinical trials and pharmaceutical industry is anticipated to continue steady growth, thereby promoting the high requirement of clinical trial supplies.

U.S and Canada are home to majority of clinical trials which are conducted in this region. No language barrier is one of the major factor for the preference of this region for majority of clinical trials, as English language is widely spoken in this region. Major CRO’s and biopharmaceutical companies have their hub in this region and with advancement in technology the demand for efficient supplies are increasing and the region is expected to dominate the clinical trial supplies market over the forecast period.

Clinical Trial Supplies Market

To request a sample copy or view summary of this report, click the link below:
 www.grandviewresearch.com/industry-analysis/clinical-trial-supplies-market

Further Key Findings From the Study Suggest:
  • On the basis of clinical phase, the market is anticipated to be dominated by Phase III in 2025. The presence of large number of molecule estimated to reach Phase III by 2020 is the primary factor responsible for this prediction.
  • By services, storage and distribution is anticipated to witness the fastest growth at a CAGR of over 7.0%.
  • Key end-users of this industry are pharmaceuticals, and biologics. Biologics are expected to witness fastest growth owing to the increasing research in the field of genetics and biotechnology such as development of nanoparticle based drug delivery systems.
  • In terms of therapeutic use or clinical indication, oncology dominates the market. The highest research activity as of 2016 is being performed for this indication, which in turn is expected to drive the market.
  • Few of the industry players include Movianto GmbH, Thermo Fischer Scientific, Sharp Packaging Services, Catalent Pharma Solution, Biocair International Ltd., PCI Services, Almac Group Ltd, and Patheon Inc. Other players present in the market space include Clinigen Group Plc, Merck Serono, and Chimerix.
View more reports of this category by Grand View Research at www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the clinical trial supplies market by phase, product/service, end-use, therapeutic use and region:
Clinical Phase Outlook (Revenue, USD Million; 2014 - 2025)
  • Phase I
  • Phase II
  • Phase III
  • Others
Product/Service Outlook (Revenue, USD Million; 2014 - 2025)
  • Manufacturing
  • Storage & distribution
    • Cold chain based
    • Non-cold chain based
  • Supply chain management
End-Use Outlook (Revenue, USD Million; 2014 - 2025)
  • Pharmaceuticals
  • Biologics
  • Medical device
  • Others
Therapeutic Use Outlook (Revenue, USD Million; 2014 - 2025)
  • Oncology
  • CNS
  • Cardiovascular
  • Infectious disease
  • Metabolic disorders
  • Others
Regional Outlook (Revenue, USD Million; 2014 - 2025)
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
  • Asia Pacific
    • China
    • Japan
  • Latin America
    • Mexico
    • Brazil
  • MEA
    • South Africa
    • Saudi Arabia

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For More Information: www.grandviewresearch.com

Comments

Post a Comment

Popular posts from this blog

Matcha Market Is Anticipated to Attain Around $5.07 Billion By 2025

Image
San Francisco, 29 April 2019 – “ Matcha Market Analysis By Grade (Ceremonial, Classic, Culinary), By Application (Regular Tea, Matcha Beverages, Food, Personal Care), By Region, And Segment Forecasts, [2018 - 2025] ” The global matcha market is expected to reach USD 5.07 billion by 2025, according to a new report by Grand View Research, Inc. Rising prevalence of chronic diseases has augmented the demand for healthy and nutrient-rich food & beverage alternatives. Anti-oxidant and vitamin-rich composition of matcha tea has fueled the product demand across the globe. Anti-oxidants, including epigallocatechin gallate (EGCG), prevent diseases such as cancer, Type-2 diabetes, cardiovascular problems. EGCG present in the product can repair DNA damage caused by UV radiation and controls the proliferation of cancerous cells. The product also has the potential to reduce stress and promotes a state of relaxation. L-theanine present in the product acts in a synergistic way to activa...
Read more

Levulinic acid Market Strategy, Distributors & Manufacturing Cost Analysis Till 2020

Image
Global  levulinic acid market  demand was 2,606.2 tons in 2013 and is projected to be 3,820 tons by 2020. The increasing application of levulinic acid, especially in pesticides, solvents, pharmaceuticals, and cosmetics industries are anticipated to boost growth in the coming years. Over the past few years, the chemical industry has continually been striving towards attaining a sustainable growth, with a focus on the development of renewable biotechnological and bio-based products. The production technology for bio-based levulinic acid has been simplified by dehydration of biomass or carbohydrates with acid. Levulinic acid is being increasingly used as a substitute to its synthetic counterparts in industrial usage. Levulinic acid market volume share by application, 2013 The global levulinic acid market is anticipated to reach USD 19.65 million revenue, with a growing CAGR of 4.8% by 2020. Increasing usage of the acid in niche applications including plastics, nyl...
Read more

Conductive Ink Market Forecast to 2024 With Key Companies Profile & Cost Structure Analysis

Image
San Francisco, 27 March 2019 –  “Conductive Ink Market Analysis By Product (Conductive Silver Ink, Conductive Copper Ink, Conductive Polymer, Carbon Nanotube Ink, Dielectric Ink, Carbon/Graphene Ink), By Application (Photovoltaic, Membran eSwitches, Displays, Automotives, Smart Packaging/RFID, Biosensors, Printed Circuit Boards) And Segment Forecasts To 2024” The global  conductive ink market  is expected to reach USD 4.37 billion by 2024, according to a new report by Grand View Research, Inc. Robust demand for miniaturization coupled with efficiency in the electronics industry is expected to fuel the global conductive ink market over the forecast period. These inks are also likely to replace bulky energy consuming wire and circuits in the future. Conductive inks are smaller in size and provide better durability & efficiency as compared to traditional wire circuits. Factors such as lack of product education, advertisements and information sharing on the part o...
Read more